EVOQ Therapeutics Collaborates with Sanofi to Treat Autoimmune Diseases EVOQ Therapeutics has announced a significant collaboration with Sanofi, focusing on innovative treatments for autoimmune diseases using their proprietary NanoDisc technology.

EVOQ Therapeutics Collaborates with Sanofi to Treat Autoimmune Diseases #United_States #Chicago #Sanofi #Autoimmune_Diseases #EVOQ_Therapeutics

EVOQ Therapeutics Secures $2 Million NIH Grant for Celiac Disease Treatments EVOQ Therapeutics has received a $2 million grant from the NIH to enhance therapies for celiac disease, an autoimmune condition affecting millions. This funding accelerates their innovative research.

EVOQ Therapeutics Secures $2 Million NIH Grant for Celiac Disease Treatments #USA #Ann_Arbor #Autoimmune_Disease #Celiac_Disease #EVOQ_Therapeutics